NOTIFICATION: The Technology Channels will soon be discontinued.
Click here to download complimentary copies of Fastmarkets RISI’s pulp and paper newsletters.


Reelvision Print's sales director Deborah Greenwood reveals packaging is key to crash growing counterfit medicine market

Read so far

Reelvision Print's sales director Deborah Greenwood reveals packaging is key to crash growing counterfit medicine market

April 06, 2021 - 07:46

LANCASHIRE, UK , April 6, 2021 (Press Release) -Counterfeit Medication is growing in both volume and sophistication. Innovation within Pharmaceutical Carton Packaging will help Conquer the Growing Fake Medication Market.

According to data from the World Health Organization, around one in ten medicinal products sold in low and middle-income countries are falsified. These fake products often contain no active ingredient or the wrong ingredients, failing to treat the diseases for which they are intended, or actively causing harm to the patient in question.

Fake medicines are estimated to cost the pharmaceutical sector €10.2 billion and there is considerable evidence that the COVID-19 pandemic has accelerated this problem due to a surge in demand for antivirals, supplements, and fake chloroquine, a drug often touted as a COVID-19 therapy.

The threat posed to the pharmaceutical industry by counterfeit drugs medicines is on the rise – and could be set to get worse unless businesses act now.

The UK has just a few pharmaceutical accredited carton production outlets that offer a range of in-built security features. Deborah Greenwood, Sales Director of Reelvision Print based in Lancashire explains how they are helping their clients protect their brand from being copied. 

“To stay one step ahead we approach security within pharmaceutical packaging by applying some creative thinking. We cannot give too much away but I can tell you we have a variety of methods including the use of optical brightener technology, holograms, hidden RFID units, micro text, coin reactive inks, and any combinations of the above”

The only way to tackle this issue is to view medicine for what it is, a high-value commodity open to forgery which needs security to match our everyday currency.

Pharmaceutical manufacturers and suppliers need to invest in a rigorous approach to product testing and quality assurance, backed by the very latest in carton packaging technology to ensure they are a step ahead of the counterfeiters.

About the author

Deborah Greenwood has been an ambassador in the pharmaceutical packaging industry for over 25 years and currently an advocate for driving quality in this sector, providing PS9000:2016 certified carton box packaging currently based at Reelvision Print in Lancashire.